Skip to main content
Top
Published in: Journal of Ocular Biology, Diseases, and Informatics 2-4/2008

Open Access 01-12-2008 | Review

Mechanisms of immune privilege in the anterior segment of the eye: what we learn from corneal transplantation

Author: Junko Hori

Published in: Journal of Ocular Biology, Diseases, and Informatics | Issue 2-4/2008

Login to get access

Abstract

The eye, like the brain and reproductive organs, possesses inherent immune privilege, and inflammation is self-regulated so as to preserve the organ functions. Studies over the past 30 years have provided insights of the multiple mechanisms of immune privilege. At present, three major lines of thought prevail regarding the molecular mechanisms of immune privilege in the eye: there are (1) anatomical, cellular, and molecular barriers in the eye; (2) eye-derived immunological tolerance, the so-called anterior chamber-associated immune deviation; and (3) immune suppressive intraocular microenvironment. In this review, the mechanisms of immune privilege that have been learned from ocular inflammation animal models, especially corneal transplantation, are described. Roles of new B7 family molecules on local immune regulation within the cornea are also introduced.
Literature
1.
go back to reference Streilein JW. Ocular immune privilege: therapeutic opportunities from an experiment of nature. Nat Rev Immuno. 2003;3:879–89.CrossRef Streilein JW. Ocular immune privilege: therapeutic opportunities from an experiment of nature. Nat Rev Immuno. 2003;3:879–89.CrossRef
2.
go back to reference Niederkorn JY. See no evil, hear no evil, do no evil: the lessons of immune privilege. Nat Rev Immuno. 2006;7:354–9.CrossRef Niederkorn JY. See no evil, hear no evil, do no evil: the lessons of immune privilege. Nat Rev Immuno. 2006;7:354–9.CrossRef
3.
go back to reference Hori J, Streilein JW. Survival in high-risk eyes of epithelium-deprived orthotopic corneal allografts reconstituted in vitro with syngeneic epithelium. Invest Ophthalmol Vis Sci. 2003;44:658–64.PubMedCrossRef Hori J, Streilein JW. Survival in high-risk eyes of epithelium-deprived orthotopic corneal allografts reconstituted in vitro with syngeneic epithelium. Invest Ophthalmol Vis Sci. 2003;44:658–64.PubMedCrossRef
4.
go back to reference Medawar PB. Immunity to homologous grafted skin. III. The fate of skin homografts transplanted to the brain, to subcutaneous tissue, and to the anterior chamber of the eye. Br J Exp Pathol. 1948;29:58–69.PubMed Medawar PB. Immunity to homologous grafted skin. III. The fate of skin homografts transplanted to the brain, to subcutaneous tissue, and to the anterior chamber of the eye. Br J Exp Pathol. 1948;29:58–69.PubMed
5.
go back to reference Streilein JW, Toews GB, Bergstresser PR. Corneal allografts fail to express Ia antigens. Nature 1979;282:326–7.PubMedCrossRef Streilein JW, Toews GB, Bergstresser PR. Corneal allografts fail to express Ia antigens. Nature 1979;282:326–7.PubMedCrossRef
6.
go back to reference Wang HM, Kaplan HJ, Chan WC, et al. The distribution and ontogeny of MHC antigens in murine ocular tissue. Invest Ophthalmol Vis Sci. 1987;28:1383–9.PubMed Wang HM, Kaplan HJ, Chan WC, et al. The distribution and ontogeny of MHC antigens in murine ocular tissue. Invest Ophthalmol Vis Sci. 1987;28:1383–9.PubMed
7.
go back to reference Sonoda Y, Streilein JW. Orthothopic corneal transplantation in mice—evidence that the immunogeneic rules of rejection do not apply. Transplantation 1992;54:694–704.PubMedCrossRef Sonoda Y, Streilein JW. Orthothopic corneal transplantation in mice—evidence that the immunogeneic rules of rejection do not apply. Transplantation 1992;54:694–704.PubMedCrossRef
8.
go back to reference Streilein JW, Arancibia CC, Osawa H. In adequate HLA matching in keratoplasty. In: Sundmacher R, editor. Developmental ophthalmology. vol 36. Basel: Karger AG; 2003. p. 74–88. Streilein JW, Arancibia CC, Osawa H. In adequate HLA matching in keratoplasty. In: Sundmacher R, editor. Developmental ophthalmology. vol 36. Basel: Karger AG; 2003. p. 74–88.
9.
go back to reference Hamrah P, Zhang Q, Liu Y, et al. Novel characterization of MHC class II-negative population of resident corneal Langerhans cell-type dendritic cells. Invest Ophthalmol Vis Sci. 2002;43:639–46.PubMed Hamrah P, Zhang Q, Liu Y, et al. Novel characterization of MHC class II-negative population of resident corneal Langerhans cell-type dendritic cells. Invest Ophthalmol Vis Sci. 2002;43:639–46.PubMed
10.
go back to reference Sonoda Y, Streilein JW. Impaired cell-mediated immunity in mice bearing healthy orthotopic corneal allograft. J Immunol. 1993;150:1727–34.PubMed Sonoda Y, Streilein JW. Impaired cell-mediated immunity in mice bearing healthy orthotopic corneal allograft. J Immunol. 1993;150:1727–34.PubMed
11.
go back to reference Hara Y, Caspi RR, Wiggert B, Chan CC, Streilein JW. Use of ACAID to suppress interphotoreceptor retinoid binding protein-induced experimental autoimmune uveitis. Curr Eye Res. 1992;11(Suppl):97–100.PubMedCrossRef Hara Y, Caspi RR, Wiggert B, Chan CC, Streilein JW. Use of ACAID to suppress interphotoreceptor retinoid binding protein-induced experimental autoimmune uveitis. Curr Eye Res. 1992;11(Suppl):97–100.PubMedCrossRef
12.
go back to reference Rochat C, Polla BS, Herbort CP. Immunological profiles in patients with acute retinal necrosis. Graefes Arch Clin Exp Ophthalmol. 1996;234:547–52.PubMedCrossRef Rochat C, Polla BS, Herbort CP. Immunological profiles in patients with acute retinal necrosis. Graefes Arch Clin Exp Ophthalmol. 1996;234:547–52.PubMedCrossRef
13.
go back to reference Kezuka T, Sakai J, Usui N, Streilein JW, Usui M. Evidence for antigen-specific immune deviation in patients with acute retinal necrosis. Arch Ophthalmol. 2001;119:1044–9.PubMed Kezuka T, Sakai J, Usui N, Streilein JW, Usui M. Evidence for antigen-specific immune deviation in patients with acute retinal necrosis. Arch Ophthalmol. 2001;119:1044–9.PubMed
14.
go back to reference Kezuka T. Immune deviation and ocular infections with varicella zoster virus. Ocul Immunol Inflamm. 2004;12:17–24.PubMedCrossRef Kezuka T. Immune deviation and ocular infections with varicella zoster virus. Ocul Immunol Inflamm. 2004;12:17–24.PubMedCrossRef
15.
go back to reference Willbanks GA, Mammolenti MM, Streilein JW. Studies on the induction of anterior chamber-associated immune deviation(ACAID). III. Induction of ACAID depends upon intraocular transforming growth factor-β2. Eur J Immunol. 1992;22:165–173.CrossRef Willbanks GA, Mammolenti MM, Streilein JW. Studies on the induction of anterior chamber-associated immune deviation(ACAID). III. Induction of ACAID depends upon intraocular transforming growth factor-β2. Eur J Immunol. 1992;22:165–173.CrossRef
16.
go back to reference Sheibani N, Sorenson CM, Cornelius LA, et al. Thrombospondid-1, a natural binhibitor of angiogenesis, is present in vitreous and aqueous humor and is modulated by hyperglycemia. Biochem Biophys Res Commun. 2000;267:257–68.PubMedCrossRef Sheibani N, Sorenson CM, Cornelius LA, et al. Thrombospondid-1, a natural binhibitor of angiogenesis, is present in vitreous and aqueous humor and is modulated by hyperglycemia. Biochem Biophys Res Commun. 2000;267:257–68.PubMedCrossRef
17.
go back to reference Willbanks GA, Streilein JW. Studies on the induction of anterior chamber-associated immune deviation (ACAID). 1 Evidence that an antigen-specific, ACAID-inducing, cell-associated signal exists in the peripheral blood. J Immunol. 1991;146:2610–7. Willbanks GA, Streilein JW. Studies on the induction of anterior chamber-associated immune deviation (ACAID). 1 Evidence that an antigen-specific, ACAID-inducing, cell-associated signal exists in the peripheral blood. J Immunol. 1991;146:2610–7.
18.
go back to reference Wang Y, et al. Blood mononuclear cells induce regulatory NKT thymocytes in anterior chamber-associated immune deviation. J Leukoc Biol. 2001;69:741–6.PubMed Wang Y, et al. Blood mononuclear cells induce regulatory NKT thymocytes in anterior chamber-associated immune deviation. J Leukoc Biol. 2001;69:741–6.PubMed
19.
go back to reference Faunce DE, Stein-Streilein J, et al. MIP-2 recruits NKT cells on the spleen during tolerance induction. J Immunol. 2001;166:313–21.PubMed Faunce DE, Stein-Streilein J, et al. MIP-2 recruits NKT cells on the spleen during tolerance induction. J Immunol. 2001;166:313–21.PubMed
20.
go back to reference Sonoda KH, Stein-Streilein J, et al. CD1d-reactive natural killer T cells are required for development of systemic tolerance through and immune-privileged site. J Exp Med. 1999;190:1215–26.PubMedCrossRef Sonoda KH, Stein-Streilein J, et al. CD1d-reactive natural killer T cells are required for development of systemic tolerance through and immune-privileged site. J Exp Med. 1999;190:1215–26.PubMedCrossRef
21.
go back to reference Faunce DE, Stein-Streilein J, et al. NKT cells-derived RANTES recruits APCs and CD8+ T cells to the spleen during the generation of regulatory T cells in tolerance. J Immunol. 2002;169:31–8.PubMed Faunce DE, Stein-Streilein J, et al. NKT cells-derived RANTES recruits APCs and CD8+ T cells to the spleen during the generation of regulatory T cells in tolerance. J Immunol. 2002;169:31–8.PubMed
22.
go back to reference Sonoda KH, Stein-Streilein J, et al. NKT cell-derived IL-10 is essential for the differentiation of antigen-specific T regulatory cells in systemic tolerance. J Immunol. 2001;166:42–50.PubMed Sonoda KH, Stein-Streilein J, et al. NKT cell-derived IL-10 is essential for the differentiation of antigen-specific T regulatory cells in systemic tolerance. J Immunol. 2001;166:42–50.PubMed
23.
go back to reference D’Orazio TJ, Niederkorn JY. Splenic B cells are required for tolerogenic antigen presentation in the induction of anterior chamber-associated immune deviation (ACAID). Immunology 1998;95:47–55.PubMedCrossRef D’Orazio TJ, Niederkorn JY. Splenic B cells are required for tolerogenic antigen presentation in the induction of anterior chamber-associated immune deviation (ACAID). Immunology 1998;95:47–55.PubMedCrossRef
24.
go back to reference Skelsey ME, et al. Splenic B cells act as antigen presenting cells for the induction of anterior chamber-associated immune deviation. Invest Ophthalmol Vis Sci. 2003;44:5242–51.PubMedCrossRef Skelsey ME, et al. Splenic B cells act as antigen presenting cells for the induction of anterior chamber-associated immune deviation. Invest Ophthalmol Vis Sci. 2003;44:5242–51.PubMedCrossRef
25.
go back to reference Skelsey ME, et al. CD25+, interleukin-10-producing CD4+ T cells are required for suppressor cell production and immune privilege in the anterior chamber of the eye. Immunology 2003;110:18–29.PubMedCrossRef Skelsey ME, et al. CD25+, interleukin-10-producing CD4+ T cells are required for suppressor cell production and immune privilege in the anterior chamber of the eye. Immunology 2003;110:18–29.PubMedCrossRef
26.
go back to reference Nakamura T, Stein-Streilein J, et al. CD4+ NKT cells, but not conventional CD4 + T cells, are required to generate efferent CD8+ T regulatory cells following antigen inoculation in an immune privileged site. J Immunol. 2003;171:1266–71.PubMed Nakamura T, Stein-Streilein J, et al. CD4+ NKT cells, but not conventional CD4 + T cells, are required to generate efferent CD8+ T regulatory cells following antigen inoculation in an immune privileged site. J Immunol. 2003;171:1266–71.PubMed
27.
go back to reference Skelsey ME, et al. gdT cells are needed for ocular immune privilege and corneal graft survival. J Immunol. 2001;166:4327–33.PubMed Skelsey ME, et al. gdT cells are needed for ocular immune privilege and corneal graft survival. J Immunol. 2001;166:4327–33.PubMed
28.
go back to reference Niederkorn JY, Mellon J. Anterior chamber-associated immune deviation promotes corneal allograft survival. Invest Ophthalmol Vis Sci. 1996;37:2700–7.PubMed Niederkorn JY, Mellon J. Anterior chamber-associated immune deviation promotes corneal allograft survival. Invest Ophthalmol Vis Sci. 1996;37:2700–7.PubMed
29.
go back to reference Sonoda KH, Stein-Streilein J, et al. Long-term survival of corneal allografts is dependent on intact CD1d-reactive NKT cells. J Immunol. 2002;168:2028–34.PubMed Sonoda KH, Stein-Streilein J, et al. Long-term survival of corneal allografts is dependent on intact CD1d-reactive NKT cells. J Immunol. 2002;168:2028–34.PubMed
30.
go back to reference Namba K, Kitaichi N, Nishida T, et al. Identification of a-melanocyte stimulating hormone and transforming growth factor-β2. J Leukoc Biol. 2002;72:946–52.PubMed Namba K, Kitaichi N, Nishida T, et al. Identification of a-melanocyte stimulating hormone and transforming growth factor-β2. J Leukoc Biol. 2002;72:946–52.PubMed
31.
go back to reference Taylor AW, Yee DG, Streilein JW. Suppression of nitric oxide generated by inflammatory macrophages by calcitonin gene-related peptide in aqueous humor. Invest Ophthalmol Vis Sci. 1998;39:1372–8.PubMed Taylor AW, Yee DG, Streilein JW. Suppression of nitric oxide generated by inflammatory macrophages by calcitonin gene-related peptide in aqueous humor. Invest Ophthalmol Vis Sci. 1998;39:1372–8.PubMed
32.
go back to reference Apte RS, Sinha D, Mayhew E, et al. Role of macrophage migration inhibitory factor in inhibition NK cell activity. J Immunol. 1998;160:5693–6.PubMed Apte RS, Sinha D, Mayhew E, et al. Role of macrophage migration inhibitory factor in inhibition NK cell activity. J Immunol. 1998;160:5693–6.PubMed
33.
go back to reference Kennedy MC, Rosenbaum JT, Brown J. Novel production of interleukin-1 receptor antagonist peptides in normal human cornea. J Clin Invest. 1995;95:82–8.PubMedCrossRef Kennedy MC, Rosenbaum JT, Brown J. Novel production of interleukin-1 receptor antagonist peptides in normal human cornea. J Clin Invest. 1995;95:82–8.PubMedCrossRef
34.
go back to reference Shon JH, Kaplan HJ, Suk HJ, et al. Complement regulatory activity of normal human intraocular fluid is mediated by MCP, DAF, and CD59. Invest Ophthalmol Vis Sci. 2000;41:4195–4202. Shon JH, Kaplan HJ, Suk HJ, et al. Complement regulatory activity of normal human intraocular fluid is mediated by MCP, DAF, and CD59. Invest Ophthalmol Vis Sci. 2000;41:4195–4202.
35.
go back to reference Griffith TS, Brunner T, Fletcher SM, et al. FAS ligand-induced apoptosis as a mechanism of immune privilege. Science 1995;270:1189–92.PubMedCrossRef Griffith TS, Brunner T, Fletcher SM, et al. FAS ligand-induced apoptosis as a mechanism of immune privilege. Science 1995;270:1189–92.PubMedCrossRef
36.
go back to reference Hori J, Joyce NC, Streilein JW. Epithelium-deficient corneal allografts display immune privilege beneath the kidney capsule. Invest Ophthalmol Vis Sci. 2000;41:443–52.PubMed Hori J, Joyce NC, Streilein JW. Epithelium-deficient corneal allografts display immune privilege beneath the kidney capsule. Invest Ophthalmol Vis Sci. 2000;41:443–52.PubMed
37.
go back to reference Hori J, Joyce NC, Streilein JW. Immune privilege and immunogenicity reside among layers of the mouse cornea. Invest Ophthalmol Vis Sci. 2000;41:3032–42.PubMed Hori J, Joyce NC, Streilein JW. Immune privilege and immunogenicity reside among layers of the mouse cornea. Invest Ophthalmol Vis Sci. 2000;41:3032–42.PubMed
38.
go back to reference Sugita S, Streilein JW. Iris pigment epithelium expressing CD86(B7-2) directly suppresses T cell activation in vitro via binding to cytotoxic T lymphocyte-associated antigen 4. J Exp Med. 2003;198:161–71.PubMedCrossRef Sugita S, Streilein JW. Iris pigment epithelium expressing CD86(B7-2) directly suppresses T cell activation in vitro via binding to cytotoxic T lymphocyte-associated antigen 4. J Exp Med. 2003;198:161–71.PubMedCrossRef
39.
go back to reference Hori J, Wang MC, Miyashita M, et al. B7-H1-induced apoptosis as a mechanism of immune privilege of corneal allografts. J Immunol. 2006;177:5928–35.PubMed Hori J, Wang MC, Miyashita M, et al. B7-H1-induced apoptosis as a mechanism of immune privilege of corneal allografts. J Immunol. 2006;177:5928–35.PubMed
40.
go back to reference Dong H, Zhu G, Tamada K, et al. B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion. Nat Med. 1999;5:1365–9.PubMedCrossRef Dong H, Zhu G, Tamada K, et al. B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion. Nat Med. 1999;5:1365–9.PubMedCrossRef
41.
go back to reference Dong H, Strome SE, Salomao DR, et al. Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion. Nat Med. 2002;8:793–800.PubMed Dong H, Strome SE, Salomao DR, et al. Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion. Nat Med. 2002;8:793–800.PubMed
42.
go back to reference Dong H, Zhu G, Koji T, et al. B7-H1 determines accumulation and deletion of intrahepatic CD8+ T lymphocytes. Immunity 2004;20:327–36.PubMedCrossRef Dong H, Zhu G, Koji T, et al. B7-H1 determines accumulation and deletion of intrahepatic CD8+ T lymphocytes. Immunity 2004;20:327–36.PubMedCrossRef
43.
go back to reference Chapoval AL, Ni J, Lau JS, et al. B7-H3: a costimulatory molecule for T cell activation and IFN-γ production. Nat Immunol. 2001;2:269–74.PubMedCrossRef Chapoval AL, Ni J, Lau JS, et al. B7-H3: a costimulatory molecule for T cell activation and IFN-γ production. Nat Immunol. 2001;2:269–74.PubMedCrossRef
44.
go back to reference Taniguchi H, Hori J, Wang MC, et al. Role of B7-H3 on immune privilege of corneal allografts. Proc Jpn Soc Immunol. 2007;37:115. Taniguchi H, Hori J, Wang MC, et al. Role of B7-H3 on immune privilege of corneal allografts. Proc Jpn Soc Immunol. 2007;37:115.
Metadata
Title
Mechanisms of immune privilege in the anterior segment of the eye: what we learn from corneal transplantation
Author
Junko Hori
Publication date
01-12-2008
Publisher
Humana Press Inc
DOI
https://doi.org/10.1007/s12177-008-9010-6

Other articles of this Issue 2-4/2008

Journal of Ocular Biology, Diseases, and Informatics 2-4/2008 Go to the issue